iLymph

Clinical and translational biomarker-driven research

in malignant lymphoproliferative diseases  

The iLymph project

The iLymph research program aims at developing and validating biomarkers for: (1) early detection, disease progression, and recurrence of lymphoid malignancies; and, (2) risk assessment of patients with lymphoid malignancies (of B- or T-cell origin) in both the immunocompetent and immunodeficient clinical setting. As a support to these activities, iLymph projects also include development and improvement of specific technologies and methods for quantitative detection of novel biomarkers associated with lymphoid diseases.
Read more...

Upcoming Events

Contact